More than 80,000 adults and teenagers across England suffering with a chronic skin condition could have their lives transformed after NICE today (Tuesday, 24 February) recommended the first licensed ...

NHS England will roll out the first approved vitiligo treatment cream, ruxolitinib, giving nearly 100,000 people aged 12+ living with non-segmental vitiligo a real chance to restore lost skin colour ...

A cream that directly disrupts the underlying causes of the skin patches seen in the condition vitiligo will be made ...

First licensed treatment for vitiligo set to be rolled out across NHS - Vitiligo is a condition where white patches develop ...

The topical JAK inhibitor ruxolitinib has been recommended by the NICE for eligible patients with non-segmental vitiligo.

NHS England » Tens of thousands with vitiligo to be offered “life-changing” new cream on NHS to restore skin colour ...

Applied morning and evening, ruxolitinib works beneath the surface of the skin by dampening the immune signals that attack ...

The NHS have approved a new treatment for the skin condition vitiligo. The new treatment will be offered to nearly 100,000 ...

Reimbursement authority NICE has said that Incyte's JAK inhibitor cream Opzelura (ruxolitinib) can be used to treat people ...

Tens of thousands of people living with vitiligo affecting their face will now have access to the first approved ...

The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...

A Lancashire woman has spoken about her decades-long experience of living with a skin condition - but now a new treatment option has been ...